The global cutting balloons market was valued at US$ 400.2 Million in 2022 and is expected to reach US$ 725.9 Million by 2033. The drug-coated cutting balloons products with around 42.1% value share, have topped the global market within the product in 2022 and are expected to grow at a CAGR of close to 6.0% over the forecast period (2023 to 2033)
Key Market Attributes
| Market Size, 2022 | US$ 400.2 Million |
|---|---|
| Market Size, 2023 | US$ 421.2 Million |
| Market Size, 2033 | US$ 725.9 Million |
| Value CAGR (2023 to 2033) | 5.6% |
The cutting balloons market refers to the medical devices used in minimally invasive procedures to treat arterial blockages. These balloons have small blades or microtomes attached to their surface, enabling precise cutting of plaque within arteries. The market is projected to experience substantial growth in the next decade due to rising cases of cardiovascular diseases and the increasing adoption of minimally invasive procedures.
Technological advancements and improved efficacy of cutting balloons are expected to drive demand. Additionally, the growing aging population and the focus on improving healthcare infrastructure worldwide will likely contribute to the market's expansion, addressing the rising need for effective vascular treatments.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for cutting balloons was around 2.3% of the overall US$ 17.5 Billion of the global interventional cardiology devices market in 2022.
Semi Annual Market Update
| Particular | Value CAGR |
|---|---|
| H1 | 4.90% (2022 to 2032) |
| H2 | 6.22% (2022 to 2032) |
| H1 | 5.36% (2023 to 2033) |
| H2 | 5.82% (2023 to 2033) |
The cutting balloon market has witnessed significant growth from 2017 to 2022 due to its unique advantages in percutaneous coronary interventions. Unlike traditional methods, the cutting balloon reduces vessel stretch and injury by scoring the vessel longitudinally, leading to controlled disruption of atherosclerotic plaque. This innovative approach has garnered attention as it minimizes risks associated with vessel damage.
However, the market outlook for 2023 to 2033 indicates a continued upward trajectory due to growing awareness of its benefits. Coronary artery calcification poses challenges for conventional angioplasty, making cutting balloon angioplasty a preferred option. The device's microsurgical metal blades effectively incise calcifications during dilation, leading to better luminal gain and reduced risks of restenosis and stent thrombosis.
Clinical studies suggest that cutting balloon angioplasty demonstrates superiority over conventional methods in terms of acute luminal gain and reduced target vessel revascularization incidence. Despite concerns about the risk of artery lesion tear, advancements in technology and improved procedural techniques are expected to address such issues.
In conclusion, the cutting balloon market has evolved significantly, showcasing its efficacy in handling complex calcified artery lesions. The market is poised for continued growth in the coming years, driven by increased acceptance within the medical community and ongoing advancements in technology that mitigate potential complications.
Owed to the above factors, the global market is projected to grow at a CAGR of 5.6% in the forecasted period.
The provider of cutting balloons has significant opportunities in the field of coronary intervention. When dealing with patients suffering from acute coronary syndrome (ACS) and having dense blockages, there is a frequent need for preliminary widening before inserting stents. Utilizing cutting balloons (CBs) can yield superior immediate results compared to alternative scoring balloons, thereby minimizing the chances of particles breaking loose and causing complications downstream.
The innovative Wolverine cutting balloon has shown promising results in treating calcified coronary lesions, offering a potential solution to the challenges posed by calcification during angioplasty. Additionally, the study's focus on investigating the appropriate balloon-to-artery ratio (BAR) for CBs presents an opportunity to enhance procedural precision and reduce the risk of complications.
The adoption of cutting balloons in combination with drug-coated balloons (DCBs) for in-stent restenosis (ISR) lesions also opens avenues for improved patient outcomes. The study's findings suggest that combining cutting balloon angioplasty (CBA) with DCBs could lead to better results in lowering the recurrence of ISR. Moreover, the study's exploration of in-stent dilation in circumferential coronary calcifications using cutting balloons presents a breakthrough in addressing challenges associated with heavy coronary calcification during stent implantation.
These opportunities underscore the potential of cutting balloons to advance coronary intervention techniques, enhance procedural success rates, and ultimately improve patient care. The utilization of cutting balloons, particularly the innovative Wolverine model, demonstrates the service provider's commitment to delivering effective solutions for complex coronary conditions, making a significant impact in the field of interventional cardiology.
Principal Consultant
The demand for cutting balloons is influenced by several factors. Cost is a major barrier, as cutting balloons requires advanced technology and specialized training for medical professionals. Alternative treatments like traditional balloon angioplasty or stent placement are more cost-effective and less invasive. The risk of complications is another concern, as physicians and patients may opt for less risky options.
Cutting balloons are primarily used for specific cases involving calcified or tough lesions, potentially reducing their demand. Regulatory hurdles, lack of awareness among patients and healthcare providers, preference for drug-eluting stents, and inadequate healthcare infrastructure also contribute to the market's restraint. These factors collectively hinder the adoption of cutting balloons, impacting their market growth and adoption within the medical industry.
| Country | Value CAGR |
|---|---|
| United States | 5.4% |
| Germany | 4.8% |
| United Kingdom | 4.4% |
| Japan | 5.9% |
| China | 5.3% |
| India | 4.5% |
The United States occupied a 38.6% value share in the global market in 2022, and expenditure on cutting balloons in 2022 was US$ 154.3 Million.
The United States stands out as a prominent market for cutting balloons in the North American region due to the high prevalence of acute coronary syndrome (ACS) and coronary heart disease (CHD). With CHD accounting for a significant portion of deaths, ACS is a symptomatic form that demands effective treatment.
Consequently, the United States' high incidence of heart disease and chest pain-related emergency visits positions it as a key market for cutting balloon technologies.
Germany occupies a 40.3% value share in Europe in 2022, and expenditure on cutting balloons in 2022 was US$ 34.3 Billion.
Despite challenges in coordinating inpatient and outpatient care, there is a recognized need for multidisciplinary approaches, including discharge planning, lifestyle guidance, monitoring, and self-care. To address these complexities, a disease management program is set to be introduced in Germany in 2018, reflecting the country's commitment to enhancing cardiac care and making it an attractive market for cutting balloons.
In 2022, Japan held a dominant global revenue in the East Asian market and contributed around US$ 33.8 Million.
Japan's attractiveness as a highly lucrative market for cutting balloons stems from its remarkable longevity achievements.
A significant reduction in cardiovascular disease-related mortality, particularly stroke, has played a pivotal role. The prevalence of small vessel disease (arteriolosclerosis) in Japan aligns with its disease profile, mirrored in certain regions of central Asia and Africa. The decline in high blood pressure rates, coupled with improved emergency care and preventive measures, has driven these health outcomes.
To combat emerging risks like ischemic heart disease, Japan is compelled to pioneer innovative models for cardiovascular disease prevention and control, addressing chronic ailments and promoting overall health.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Market Growth Outlook by Key Products
| Products | Value CAGR |
|---|---|
| Drug-coated Cutting Balloons | 6.0% |
| Conventional Cutting Balloons | 5.4% |
| Scoring Balloons | 5.1% |
By product, drug-coated cutting balloons covered 42.1% of market shares in the world in 2022. The product predicted to rapidly expand between 2023 and 2033 is the Drug-coated balloon (DCB). With the rising prevalence of coronary artery disease (CAD), DCB treatment presents a revolutionary approach.
By delivering anti-proliferative drugs directly to vessel walls, DCB treatment offers advantages like reduced reliance on stents, immediate drug release, and potential reduction in antiplatelet therapy duration. Its applications extend to various coronary diseases, including restenosis, small vessel disease, and chronic occlusion. Multiple trials have validated its efficacy, positioning DCB as an innovative solution for CAD treatment, making it poised for rapid expansion in the coming decade.
Market Growth Outlook by Key Applications
| Application | Value CAGR |
|---|---|
| Coronary Artery Disease | 5.2% |
| Peripheral Artery Disease | 6.2% |
The market value of coronary artery disease in cutting balloons is US$ 234.1 Million, representing a sizable 58.5% market share in 2022. Cutting balloons have gained favor as a preferred choice for treating Coronary Artery Disease (CAD) due to their efficacy in addressing atherosclerotic plaque obstruction. CAD, characterized by impaired blood flow and oxygen delivery, contributes significantly to morbidity and mortality.
Cutting balloons mitigates this by utilizing microsurgical blades during balloon inflation, enabling precise plaque modification without extensive vessel trauma. This approach minimizes complications like dissections, enhancing procedural success. Given CAD's global burden and economic impact, cutting balloons offers a tailored solution to restore blood flow, reduce symptoms, and improve patient outcomes, making them a valuable tool in CAD management.
Market Growth Outlook by Key End Users
| End User | Value CAGR |
|---|---|
| Hospitals | 5.8% |
| Cardiac Centers | 5.3% |
| Ambulatory Surgical Centers | 5.6% |
The hospitals have a considerable presence in the cutting balloons market, accounting for 45.8% of end users in 2022, and exhibiting a high CAGR of 5.8% over the forecast period. The key end consumers of the global coronary artery disease market are hospitals. Hospitals are essential healthcare facilities that are crucial in the detection, treatment, and management of coronary artery disease (CAD). They provide a wide range of therapies for CAD patients, such as diagnostic procedures, surgical interventions, and rehabilitation programs.
Modern medical technology, experienced cardiologists, and interdisciplinary teams are all found in hospitals, providing efficient patient care and illness control. Hospitals are crucial recipients of developments and innovations in the worldwide coronary artery disease market because of their central role in the treatment of CAD; this improves patient outcomes and boosts the effectiveness of healthcare as a whole.
Advancements and partnerships within healthcare providers, research institutes, and tech enterprises foster cutting-edge innovation. Collaborative efforts boost market growth and diversify applications. Several prominent companies vie in the cutting balloon sector, including:
Similarly, recent developments related to the company’s manufacturing the cutting balloons have been tracked by the team at Future Market Insights, which are available in the full report.
Related Market Growth Outlook Scenario
| Particulars | Value CAGR |
|---|---|
| Angiography Devices Market | 6.2% |
| Angiographic Catheters Market | 4.3% |
| Peripheral Angioplasty Market | 7.7% |
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ Million for Value, Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA) |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, United Kingdom, Spain, BENELUX, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC countries, Türkiye, Northern Africa and South Africa. |
| Key Market Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The global market is worth USD 400.2 Million in 2022.
The global market estimate for 2023 is around USD 421.2 Million.
The global market is expected to reach USD 725.9 Million by the end of 2033
The global market grew at a CAGR of 3.8% between 2017 and 2022.
The United States contributed around USD 154.3 Million in the year 2022.
Germany holds nearly 8.6% market share in the global market in 2022.
Japan accounted for a market value share of around 8.4% in 2022 globally.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption/Usage Analysis
4.2. Products USP/ Features Analysis
4.3. Regulatory Landscape
4.3.1. Regulatory Frameworks in United States
4.3.2. Regulatory Frameworks in Europe
4.3.3. Regulatory Frameworks in India
4.3.4. Regulatory Frameworks in Australia
4.4. Porter’s Analysis
4.5. PESTLE Analysis
4.6. Value Chain Analysis
4.7. Unmet Needs
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure
5.1.2. Global Life Expectancy Market Outlook
5.1.3. Research and Development funding by Region
5.1.4. Global Breast Imaging Market Overview – Parent Market Analysis
5.2. Forecast Factors - Relevance and Impact
5.2.1. Top Companies Historical Growth
5.2.2. Increased Prevalence of Chronic Diseases
5.2.3. Technological Advancements in Molecular Diagnostics
5.2.4. New Product Launches
5.2.5. Increasing Focus on Cancer Diagnostics
5.2.6. Strategic Collaborations and Partnerships
5.2.7. Cost of Product
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand (in Volume) Analysis 2017 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Volume (Units) Analysis, 2017 to 2022
6.2. Current and Future Market Volume (Units) Analysis and Forecast, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market – Pricing Assessment
7.1. Regional Pricing Analysis
7.2. Pricing Break-up
7.3. Global Average Pricing Analysis Benchmark
7.4. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
8.2. Current and Future Market Size (US$ Million) Analysis and Forecast, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2017 to 2022
9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033
9.3.1. Drug-coated Cutting Balloons
9.3.2. Conventional Cutting Balloons
9.3.3. Scoring Balloons
9.4. Market Attractiveness Analysis By Product
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
10.3.1. Coronary Artery Disease
10.3.2. Peripheral Artery Disease
10.4. Market Attractiveness Analysis By Application
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
11.3.1. Hospitals
11.3.2. Cardiac Centers
11.3.3. Ambulatory Surgical Centers
11.4. Market Attractiveness Analysis By End User
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East and Africa
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. United States
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Market Attractiveness Analysis By Region
13.4.1. By Country
13.4.2. By Product
13.4.3. By Application
13.4.4. By End User
13.5. Market trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis and Forecast
13.8.1. United States Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Application
13.8.1.2.3. By End User
13.8.2. Canada Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Application
13.8.2.2.3. By End User
14. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis By Region
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By End User
14.5. Market trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis and Forecast
14.8.1. Brazil Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Application
14.8.1.2.3. By End User
14.8.2. Mexico Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Application
14.8.2.2.3. By End User
14.8.3. Argentina Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Application
14.8.3.2.3. By End User
15. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. United Kingdom
15.3.1.2. Germany
15.3.1.3. Italy
15.3.1.4. France
15.3.1.5. Spain
15.3.1.6. Russia
15.3.1.7. BENELUX
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis By Region
15.4.1. By Country
15.4.2. By Product
15.4.3. By Application
15.4.4. By End User
15.5. Market trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis and Forecast
15.8.1. United Kingdom Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Application
15.8.1.2.3. By End User
15.8.2. Germany Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Application
15.8.2.2.3. By End User
15.8.3. Italy Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Application
15.8.3.2.3. By End User
15.8.4. France Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Product
15.8.4.2.2. By Application
15.8.4.2.3. By End User
15.8.5. Spain Market Analysis
15.8.5.1. Introduction
15.8.5.2. Market Analysis and Forecast by Market Taxonomy
15.8.5.2.1. By Product
15.8.5.2.2. By Application
15.8.5.2.3. By End User
15.8.6. Russia Market Analysis
15.8.6.1. Introduction
15.8.6.2. Market Analysis and Forecast by Market Taxonomy
15.8.6.2.1. By Product
15.8.6.2.2. By Application
15.8.6.2.3. By End User
15.8.7. BENELUX Market Analysis
15.8.7.1. Introduction
15.8.7.2. Market Analysis and Forecast by Market Taxonomy
15.8.7.2.1. By Product
15.8.7.2.2. By Application
15.8.7.2.3. By End User
16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction / Key Findings
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Thailand
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis By Region
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.4.4. By End User
16.5. Market trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis and Forecast
16.8.1. India Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Application
16.8.1.2.3. By End User
16.8.2. Indonesia Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Application
16.8.2.2.3. By End User
16.8.3. Thailand Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Application
16.8.3.2.3. By End User
16.8.4. Malaysia Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Application
16.8.4.2.3. By End User
17. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction / Key Findings
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis By Region
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.4.4. By End User
17.5. Market trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis and Forecast
17.8.1. China Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Application
17.8.1.2.3. By End User
17.8.2. Japan Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Application
17.8.2.2.3. By End User
17.8.3. South Korea Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Application
17.8.3.2.3. By End User
18. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction / Key Findings
18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis By Region
18.4.1. By Country
18.4.2. By Product
18.4.3. By Application
18.4.4. By End User
18.5. Market trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis and Forecast
18.8.1. Australia Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Application
18.8.1.2.3. By End User
18.8.2. New Zealand Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Application
18.8.2.2.3. By End User
19. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction / Key Findings
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Türkiye
19.3.1.3. South Africa
19.3.1.4. Northern Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis By Region
19.4.1. By Country
19.4.2. By Product
19.4.3. By Application
19.4.4. By End User
19.5. Market trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis and Forecast
19.8.1. GCC Countries Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Application
19.8.1.2.3. By End User
19.8.2. Türkiye Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Application
19.8.2.2.3. By End User
19.8.3. South Africa Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Product
19.8.3.2.2. By Application
19.8.3.2.3. By End User
19.8.4. Northern Africa Market Analysis
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast by Market Taxonomy
19.8.4.2.1. By Product
19.8.4.2.2. By Application
19.8.4.2.3. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players (%)
20.3. Market Concentration
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Deep Dive
21.2.1. Abbott
21.2.1.1. Overview
21.2.1.2. Product Portfolio
21.2.1.3. Key Financials
21.2.1.4. Sales Footprint
21.2.1.5. SWOT Analysis
21.2.1.6. Strategy Overview
21.2.1.6.1. Marketing Strategies
21.2.1.6.2. Product Strategies
21.2.1.6.3. Channel Strategies
21.2.2. Boston Scientific Corporation
21.2.2.1. Overview
21.2.2.2. Product Portfolio
21.2.2.3. Key Financials
21.2.2.4. Sales Footprint
21.2.2.5. SWOT Analysis
21.2.2.6. Strategy Overview
21.2.2.6.1. Marketing Strategies
21.2.2.6.2. Product Strategies
21.2.2.6.3. Channel Strategies
21.2.3. B. Braun Melsungen AG
21.2.3.1. Overview
21.2.3.2. Product Portfolio
21.2.3.3. Key Financials
21.2.3.4. Sales Footprint
21.2.3.5. SWOT Analysis
21.2.3.6. Strategy Overview
21.2.3.6.1. Marketing Strategies
21.2.3.6.2. Product Strategies
21.2.3.6.3. Channel Strategies
21.2.4. Cook Medical
21.2.4.1. Overview
21.2.4.2. Product Portfolio
21.2.4.3. Key Financials
21.2.4.4. Sales Footprint
21.2.4.5. SWOT Analysis
21.2.4.6. Strategy Overview
21.2.4.6.1. Marketing Strategies
21.2.4.6.2. Product Strategies
21.2.4.6.3. Channel Strategies
21.2.5. Cordis
21.2.5.1. Overview
21.2.5.2. Product Portfolio
21.2.5.3. Key Financials
21.2.5.4. Sales Footprint
21.2.5.5. SWOT Analysis
21.2.5.6. Strategy Overview
21.2.5.6.1. Marketing Strategies
21.2.5.6.2. Product Strategies
21.2.5.6.3. Channel Strategies
21.2.6. Medtronic
21.2.6.1. Overview
21.2.6.2. Product Portfolio
21.2.6.3. Key Financials
21.2.6.4. Sales Footprint
21.2.6.5. SWOT Analysis
21.2.6.6. Strategy Overview
21.2.6.6.1. Marketing Strategies
21.2.6.6.2. Product Strategies
21.2.6.6.3. Channel Strategies
21.2.7. MicroPort Scientific Corporation
21.2.7.1. Overview
21.2.7.2. Product Portfolio
21.2.7.3. Key Financials
21.2.7.4. Sales Footprint
21.2.7.5. SWOT Analysis
21.2.7.6. Strategy Overview
21.2.7.6.1. Marketing Strategies
21.2.7.6.2. Product Strategies
21.2.7.6.3. Channel Strategies
21.2.8. Opto Circuits (India) Ltd.
21.2.8.1. Overview
21.2.8.2. Product Portfolio
21.2.8.3. Key Financials
21.2.8.4. Sales Footprint
21.2.8.5. SWOT Analysis
21.2.8.6. Strategy Overview
21.2.8.6.1. Marketing Strategies
21.2.8.6.2. Product Strategies
21.2.8.6.3. Channel Strategies
21.2.9. Spectranetics (Philips Healthcare)
21.2.9.1. Overview
21.2.9.2. Product Portfolio
21.2.9.3. Key Financials
21.2.9.4. Sales Footprint
21.2.9.5. SWOT Analysis
21.2.9.6. Strategy Overview
21.2.9.6.1. Marketing Strategies
21.2.9.6.2. Product Strategies
21.2.9.6.3. Channel Strategies
21.2.10. Terumo Corporation
21.2.10.1. Overview
21.2.10.2. Product Portfolio
21.2.10.3. Key Financials
21.2.10.4. Sales Footprint
21.2.10.5. SWOT Analysis
21.2.10.6. Strategy Overview
21.2.10.6.1. Marketing Strategies
21.2.10.6.2. Product Strategies
21.2.10.6.3. Channel Strategies
21.2.11. TriReme Medical, LLC (QT Vascular Ltd.)
21.2.11.1. Overview
21.2.11.2. Product Portfolio
21.2.11.3. Key Financials
21.2.11.4. Sales Footprint
21.2.11.5. SWOT Analysis
21.2.11.6. Strategy Overview
21.2.11.6.1. Marketing Strategies
21.2.11.6.2. Product Strategies
21.2.11.6.3. Channel Strategies
21.2.12. Vascular Concepts Limited
21.2.12.1. Overview
21.2.12.2. Product Portfolio
21.2.12.3. Key Financials
21.2.12.4. Sales Footprint
21.2.12.5. SWOT Analysis
21.2.12.6. Strategy Overview
21.2.12.6.1. Marketing Strategies
21.2.12.6.2. Product Strategies
21.2.12.6.3. Channel Strategies
22. Assumptions and Acronyms Used
23. Research Methodology
Explore Healthcare Insights
View Reports
Cutting Balloons Market
